Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.
The Role of B-Cell Maturation Antigen in the Biology and Management of, and as a Potential Therapeutic Target in, Multiple Myeloma.Anti-BCMA CAR-T cells for treatment of plasma cell dyscrasia: case report on POEMS syndrome and multiple myelomaClinical impact of serum soluble SLAMF7 in multiple myelomaTargeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
P2860
Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Serum B-cell maturation antige ...... for multiple myeloma patients.
@en
Serum B-cell maturation antige ...... for multiple myeloma patients.
@nl
type
label
Serum B-cell maturation antige ...... for multiple myeloma patients.
@en
Serum B-cell maturation antige ...... for multiple myeloma patients.
@nl
prefLabel
Serum B-cell maturation antige ...... for multiple myeloma patients.
@en
Serum B-cell maturation antige ...... for multiple myeloma patients.
@nl
P2093
P2860
P1433
P1476
Serum B-cell maturation antige ...... for multiple myeloma patients.
@en
P2093
Ariana Berenson
Cathy S Wang
Claudia Andreu-Vieyra
Eric Sanchez
Haiming Chen
James R Berenson
Jillian Gottlieb
Michael Ghermezi
Mingjie Li
P2860
P304
P356
10.3324/HAEMATOL.2016.150896
P577
2016-12-29T00:00:00Z